Arizona State University in the US and Sun Yat-Sen University in China are working together to develop early and predictive diagnostics to improve outcomes for patients with colorectal cancer.
The research collaboration includes discovery, development and validation of biomarkers to screen high-risk populations and detect colon cancer at an early stage.
Leland Hartwell, chief scientist at Arizona State University’s Biodesign Institute Center for Sustainable Health, said that developing these advances to the stage where they are useful in a clinic requires a systematic, dedicated, and long-term collaboration between the most advanced clinical research sites and technology centres.
”We are optimistic that this collaboration will help advance the quality of colorectal cancer care worldwide,” Hartwell said.
